To explore the molecular mechanism by which LMP10 KO attenuates Ang II-induced cardiac hypertrophy, we examined a range of prohypertrophic signaling pathways, including IGF1R, gp130, EGFR, and calcineurin A, and their downstream mediators. Here, EGFR is linked to cardiac hypertrophy.